The Company is engaged in developing and employing innovative technology to produce synthetic liquid hydrocarbons that are free of contaminants normally found in conventional products made from crude oil.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
SYNM is on the verge of turning a consistent profit. With a 1.28 per gallon margin on biodiesel, this stock should yeild .40/share or more annually. If the tax credit doesn't get extended, RIN values will adjust to compensate.
It is absolutely befuddling how shares are still trading this low given the recent Solazyme debut. For crying out loud, Solazyme's market cap is already nearly nine times that of SYNM when SYNM has an operational commercial scale plant and Solazyme has only recently announced plans for commercial facilities... Syntroleum's price seems to be being held back due to its lengthy trading history and past volatility, but sooner or later this one will be on wall street's radar and shares should be several times more what they are currently trading for.